The Federal University of Minas Gerais (UFMG) extended to October 15 the testing period for the vaccine developed by the Chinese company Sinovac Biotec, considered one of the most promising against the coronavirus. Health professionals who work on the frontline of the fight against Covid-19 in Minas Gerais can participate.
The university also increased the age range of volunteers. The changes include elderly people between 60 and 80 years old. According to the new rule, the volunteer may or may not have been infected by the virus. Women cannot be pregnant or expect to become pregnant in the coming months
With the expanded age range, volunteers with chronic diseases, such as diabetes or hypertension, will now also be accepted.
In Brazil, the research is coordinated by the Butantan Institute, in São Paulo. In Minas, the tests started on August 31 and are developed by the Center for Research and Development of Pharmaceuticals of the Institute of Biological Sciences of UFMG.
Doctors, nurses, nursing technicians, physiotherapists and other health professionals can enroll, who must meet the following requirements:
- not participating in other experiments
- have active registration on the professional board of your trade
The volunteer who meets these criteria and is interested in participating must do contact by (31) 97171 2657.
Chinese vaccine Coronavac begins to be tested in BH and São Caetano do Sul (SP)
Developed by Sinovac Biotech, Coronavac is considered one of the most promising by the State Department of Health (SES) of Minas Gerais.
The vaccine uses technology that involves the virus purified and inactivated, whose effectiveness is already proven against influenza, polio, diphtheria, tetanus and hepatitis.
An article in the journal Science showed that the vaccine induced the production of antibodies to SARS-CoV-2 in mice, rats and non-human primates. Sinovac Biotech has also carried out tests on around 1,000 Chinese volunteers in phases 1 and 2.
Across Brazil, 9,000 people will participate in the tests. In Minas Gerais, there will be 852. After receiving the doses, the volunteers will be followed for a period that can exceed one year.